Fornier M - Search Results

1

Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.

Nisticò C, Cuppone F, Bria E, Fornier M, Giannarelli D, Mottolese M, Novelli F, Natoli G, Cognetti F, Terzoli E. Nisticò C, et al. Among authors: fornier m. Anticancer Drugs. 2006 Nov;17(10):1193-200. doi: 10.1097/01.cad.0000231485.17063.d3. Anticancer Drugs. 2006. PMID: 17075319

2

Oral minoxidil for late alopecia in cancer survivors.

Kuo AM, Reingold RE, Ketosugbo KF, Pan A, Kraehenbuehl L, Dusza S, Gajria D, Lake DE, Bromberg JF, Traina TA, Fornier MN, Gucalp A, D'Alessandro BM, Rotemberg V, Dauscher M, Shapiro J, Goldfarb SB, Markova A, Lacouture ME. Kuo AM, et al. Among authors: fornier mn. Breast Cancer Res Treat. 2024 Dec;208(3):491-499. doi: 10.1007/s10549-024-07440-5. Epub 2024 Aug 4. Breast Cancer Res Treat. 2024. PMID: 39097564

3

Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer.

Fornier M, Esteva FJ, Seidman AD. Fornier M, et al. Semin Oncol. 2000 Dec;27(6 Suppl 11):38-45; discussion 92-100. Semin Oncol. 2000. PMID: 11236027 Review.

4

Adjuvant chemotherapy for primary breast cancer.

Fornier M, Hudis C. Fornier M, et al. Curr Oncol Rep. 2005 Jan;7(1):18-22. doi: 10.1007/s11912-005-0021-1. Curr Oncol Rep. 2005. PMID: 15610682 Review.

5

Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate.

Fornier MN, Seidman AD, Schwartz MK, Ghani F, Thiel R, Norton L, Hudis C. Fornier MN, et al. Ann Oncol. 2005 Feb;16(2):234-9. doi: 10.1093/annonc/mdi059. Ann Oncol. 2005. PMID: 15668276 Free article.

6

Dose-dense adjuvant chemotherapy for primary breast cancer.

Fornier M, Norton L. Fornier M, et al. Breast Cancer Res. 2005;7(2):64-9. doi: 10.1186/bcr1007. Epub 2005 Feb 10. Breast Cancer Res. 2005. PMID: 15743513 Free PMC article.

7

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.

Fornier MN, Modi S, Panageas KS, Norton L, Hudis C. Fornier MN, et al. Cancer. 2005 Oct 15;104(8):1575-9. doi: 10.1002/cncr.21385. Cancer. 2005. PMID: 16134178 Free article.

8

Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials.

Bria E, Cuppone F, Fornier M, Nisticò C, Carlini P, Milella M, Sperduti I, Terzoli E, Cognetti F, Giannarelli D. Bria E, et al. Among authors: fornier m. Breast Cancer Res Treat. 2008 May;109(2):231-9. doi: 10.1007/s10549-007-9663-z. Epub 2007 Jul 19. Breast Cancer Res Treat. 2008. PMID: 17638068 Review.

9

Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study.

Nisticò C, Bria E, Cuppone F, Fornier M, Sperduti I, Carpino A, Pace A, Cognetti F, Terzoli E. Nisticò C, et al. Among authors: fornier m. Anticancer Drugs. 2007 Jul;18(6):687-92. doi: 10.1097/CAD.0b013e328035f863. Anticancer Drugs. 2007. PMID: 17762397 Clinical Trial.

10

Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.

Ali SM, Carney WP, Esteva FJ, Fornier M, Harris L, Köstler WJ, Lotz JP, Luftner D, Pichon MF, Lipton A; Serum HER-2/neu Study Group. Ali SM, et al. Among authors: fornier m. Cancer. 2008 Sep 15;113(6):1294-301. doi: 10.1002/cncr.23689. Cancer. 2008. PMID: 18661530 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters